Drug interaction study tests safety of combining itraconazole with BI 1815368
NCT ID NCT05965583
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 1 trial studied 14 healthy men to see if taking itraconazole (an antifungal) changes how the body absorbs an experimental drug called BI 1815368. Participants received BI 1815368 alone and then again with itraconazole. The goal was to measure drug levels in the blood to guide future dosing recommendations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BI 1815368 and itraconazole
- What this could lead to
- If successful, this study will help determine safe dosing of BI 1815368 when taken with itraconazole, supporting future trials in patients.
- What could go wrong
- This is a small, early-stage drug interaction study in healthy volunteers, not patients. Results may not predict effects in sicker populations or with long-term use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test